These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 589607)
1. Fibrinolysis and antifibrinolytic drugs in the growth and spread of tumours. Peterson H Cancer Treat Rev; 1977 Sep; 4(3):213-7. PubMed ID: 589607 [TBL] [Abstract][Full Text] [Related]
2. The role of hemostasis and fibrinolysis in the metastatic spread of cancer. Markus G Semin Thromb Hemost; 1984 Jan; 10(1):61-70. PubMed ID: 6538342 [No Abstract] [Full Text] [Related]
3. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis]. Ojiro M Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232 [No Abstract] [Full Text] [Related]
5. [Hemostasis and tumor invasion. Therapeutic implications]. Cattan A Bull Cancer; 1984; 71(5):481-93. PubMed ID: 6395923 [TBL] [Abstract][Full Text] [Related]
6. [Cancer, hemostasis and coaguloactive drugs]. Nadiradze ISh Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281 [No Abstract] [Full Text] [Related]
7. [Tumor fibrinolysis and antifibrinolytic agents]. Peterson HI Lakartidningen; 1978 Feb; 75(6):441-3. PubMed ID: 628254 [No Abstract] [Full Text] [Related]
8. Effect of fibrinolytic and antifibrinolytic therapy on the dissemination of experimental tumours. Rudenstam CM Bibl Anat; 1967; 9():418-24. PubMed ID: 4226503 [No Abstract] [Full Text] [Related]
9. Macromolecular ensembles of internal and external fibrinolysis: the resources for enhancement of thrombolysis efficacy. Maksimenko AV; Tischenko EG Curr Med Chem; 2006; 13(14):1617-25. PubMed ID: 16787208 [TBL] [Abstract][Full Text] [Related]
10. [Hemostatic mechanisms and malignant tumors]. Kase F; Pospísil J; Hlousková D Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210 [TBL] [Abstract][Full Text] [Related]
11. Therapeutics targeting the fibrinolytic system. Lin H; Xu L; Yu S; Hong W; Huang M; Xu P Exp Mol Med; 2020 Mar; 52(3):367-379. PubMed ID: 32152451 [TBL] [Abstract][Full Text] [Related]
15. Extrinsic plasminogen activator: a new principle in fibrinolysis. Lijnen HR Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789 [TBL] [Abstract][Full Text] [Related]
16. [Fibrinolytic system in atherogenesis]. Kołodziejczyk J; Nowak P Postepy Biochem; 2004; 50(3):248-55. PubMed ID: 15822754 [No Abstract] [Full Text] [Related]
17. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy]. Veremeenko KN; Kizim AI Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892 [TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis associated with human neoplasia: production of plasminogen activator by human tumours. Nagy B; Ban J; Brdar B Int J Cancer; 1977 May; 19(5):614-20. PubMed ID: 863542 [TBL] [Abstract][Full Text] [Related]
19. Haemostasis and cancer. Francis JL Med Lab Sci; 1989 Oct; 46(4):331-46. PubMed ID: 2693872 [TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic activity in human tumor tissues. Yuen P; Kwaan HC Cancer Invest; 1983; 1(5):369-78. PubMed ID: 6686789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]